from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1611/trpC

LFCtreatmentdescriptionclass of inhibitor

0.091

Amikacinug/mL Amikacintranslation

0.005

Cap5-10ug/mL Capreomycintranslation

-0.397

Rox10-50 ug/mL Roxithromycintranslation

0.458

SM2-5 ug/mL Streptomycintranslation

0.250

Tet5-10 ug/mL Tetracyclinetranslation

1.289

Rif0.2-5ug/mL Rifampicintranscription

0.373

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.271

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.390

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.999

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.267

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.028

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.070

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.337

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.761

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.101

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.213

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.501

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.685

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.321

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.632

KCN5-20 ug/mL Potassium cyaniderespiration

-0.178

NaN30.2-2 mM Sodium aziderespiration

0.198

Nigericin50 uM Nigericinrespiration

-0.636

TRC10-150 ug/mL Triclosanrespiration

-1.798

TRZ10-25 ug/mL Thioridazinerespiration

-1.738

Valinomycin0.5-10 uM Valinomycinrespiration

0.651

ZnSO42 mM ZnSO4respiration

-0.070

menadione6-10 ug/mL Menadionerespiration

-0.253

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.532

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.375

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.340

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.308

NRP_1Non-replicating persistence stage 1dosRassociated

0.483

Amp0.2mg/mL AmpicillincellWall

0.245

Cephalexin20-100 ug/mL CephalexincellWall

0.255

Cerulenin0.32-5 ug/mL CerulenincellWall

1.019

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.822

EMB10-20 ug/mL EthambutolcellWall

0.920

Eta12-40 ug/mL EthionamidecellWall

1.443

INH0.2-0.4 ug/mL IsoniazidcellWall

1.016

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.211

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.265

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.180

BZA0.12 mg/mL BenzamidearomaticAmides

0.059

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.009

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.399

H2O24 mM hydrogen peroxideDNAdamaging

0.228

Levo10 ug/mL LevofloxacinDNAdamaging

0.615

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.756

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.866

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.750

UVUV-irradiationDNAdamaging

-0.569

ARP41-4 ug/mL Antitubercular compound ARP4?

0.668

Antimycin12.5-50 ug/mL Antimycin A?

0.236

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.181

PA_110-50 ug/mL Antitubercular compound PA-1?

0.340

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.724

PA8240.2-2 ug/mL PA-824?

-1.004

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.178

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.089

Verapamil50 uM Verapamil?

0.007

mercaptoethanol2 mM 2-Mercaptoethanol?

0.081

methoxatin10-20 ug/mL Methoxatin?